The acquisition of Santiane by Kereis represents a strategic move, driven by the latter's intention to expand its market footprint and reinforce its position in the French insurance industry. Through this transaction, Kereis aims to leverage Santiane's expertise in the health and prevoir sector, while also diversifying its service offerings and strengthening its distribution network. The deal is expected to create synergies, driven by the complementary nature of the two companies' operations. By partnering with Santiane, Kereis seeks to build a leading player in the French insurance market, driven by its commitment to delivering high-quality services and building long-term relationships with its clients. The operation includes a clause of earn-out, indexed on the future performance of Santiane. The management is expected to reinvest approximately 50 million euros in the company, demonstrating their confidence in the future prospects of the business. As Kereis continues to navigate its new phase of development under the ownership of Advent International, the acquisition of Santiane is expected to play a key role in driving the company's growth and expansion in the French insurance market.

Bridgepoint has acquired a majority stake in Financière CEP from the American private equity firm JC Flowers & Co and the group's founder, Hubert Guillard. This secondary LBO follows an unsuccessful sale process in 2017. The transaction was secured via a preemptive offer signed in early March 2020, just before the COVID-19 lockdowns. The management team, led by CEO Philippe Gravier, is reinvesting alongside Bridgepoint to support an ambitious growth project. The strategic rationale for the deal is to capitalize on CEP's leadership in the French loan insurance and mortgage brokerage markets. Bridgepoint aims to accelerate the group's digital investments and pursue a strategy of international diversification and product expansion across Europe.